FREEMAN KEVIN D 4
4 · GALECTIN THERAPEUTICS INC · Filed Oct 31, 2022
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2022-10-28$1.41/sh+10,000$14,100→ 75,000 total(indirect: By LLC)
Holdings
- 23,469
Common Stock
- 16,000(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.